Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Treatment.com AI Inc TREIF


Primary Symbol: C.TRUE

Treatment.com AI Inc., through its wholly owned subsidiary, Treatment.com Inc., is in the business of providing personalized health care information. The Company has developed a personalized healthcare artificial intelligence (AI) engine, the Global Library of Medicine (GLM), which is engaged in providing clinical information and support to all healthcare professionals. The GLM delivers over 92% accuracy on first diagnosis as well as providing recommended tests (physical and lab), x-rays, and billing codes. Its solutions include medical education solution, medical clinic solution and clinical advisor solution. It also focuses on the next generation of healthcare professionals supporting medical and nursing schools, who utilize the GLM to help improve the clinical skills of their students. It is also focused on using AI for utilizing its GLM platform to bring the possibility of health equity and inclusion for disenfranchised communities.


CSE:TRUE - Post by User

Post by Betteryear2on Sep 07, 2021 11:08pm
232 Views
Post# 33823461

Prepares AI Technology for Scale

Prepares AI Technology for Scale

VANCOUVER, British Columbia, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE) (OTC: TREIF), a healthcare AI technology company, has created an infrastructure designed for global scale to support better access to healthcare information for everyone. Over the past 12 weeks, Treatment has enlisted the support of developers, digital infrastructure designers and consumer research agencies to test and enhance its product and technology in preparation for launch and future growth.

“We have just completed 12 rounds of user testing running our technology through over 350 consumers and are very pleased to see the overwhelmingly positive response. Consumers are excited to use our healthcare AI to help them make better healthcare decisions and we see the potential to take this around the globe,” commented CEO, John Fraser. “We have taken the time to finesse our technology so when we decide to scale our capabilities and markets we can accomplish that in a very short time.”

With the implementation of a more scalable technology infrastructure, Treatment will be focusing more energy on the development of the go-to-market plan for their first product launch and building awareness in the investor community.

"This fall, we will turn our focus to building the launch plan for our first product and building our investor relations to ensure that we will take our place amongst the most disruptive healthcare companies in the world. We are financially sound, maintain a compressed burn rate and continue to source expert consultants to ensure we achieve success,” Fraser stated. "We welcome all our investors to keep abreast of our progress."

Treatment.com will launch its much anticipated first product, a consumer mobile app Cara this year.

About Treatment.com

Treatment.com is a disruptive healthcare technology company that is harnessing the power of AI to help consumers improve their health through personalized recommendations and insights. Based in Vancouver and Minneapolis, the company spent the last five years working with a team of world-class doctors, engineers, mathematicians, and AI specialists to develop a complex AI engine that leverages the most robust, personalized data to generate highly predictive and accurate insights. Treatment.com is the parent company of Cara. Cara empowers consumers to take control of their health with the launch of an innovative mobile app powered by this exclusive AI engine.

For more investor information on Treatment.com please visit https://treatment.com/investors/.

 
<< Previous
Bullboard Posts
Next >>